Get the Stockscreener App
260.60
1.98%
5.05
After Hours:
258.50
-2.10
-0.81%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $260.60, with a volume of 1.45M.
It is up +1.98% in the last 24 hours and up +8.57% over the past month.
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$255.55
Open:
$256.2
24h Volume:
1.45M
Relative Volume:
0.71
Market Cap:
$30.77B
Revenue:
$112.04B
Net Income/Loss:
$1.71B
P/E Ratio:
10.80
EPS:
24.12
Net Cash Flow:
$-5.05B
1W Performance:
+1.10%
1M Performance:
+8.57%
6M Performance:
-18.70%
1Y Performance:
-45.37%
1-Day Range:
$252.21
$261.93
1-Week Range:
$251.83
$273.28
52-Week Range:
$213.31
$527.18
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
500 W MAIN ST, LOUISVILLE, KY
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
HumanaQ3 Earnings Review: The Medicare Advantage Madness May Finally Be Over (NYSE:HUM) - Seeking Alpha
Humana's SWOT analysis: stock faces star ratings challenge, outlook uncertain - Investing.com
National Pension Service Increases Stake in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Sees Unusually Large Options Volume (NYSE:HUM) - MarketBeat
Wells Fargo & Company Has Lowered Expectations for Humana (NYSE:HUM) Stock Price - MarketBeat
New York State Common Retirement Fund Cuts Stock Position in Humana Inc. (NYSE:HUM) - MarketBeat
Leerink Partnrs Has Negative Estimate for Humana Q4 Earnings - MarketBeat
US Bancorp DE Has $8.97 Million Position in Humana Inc. (NYSE:HUM) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc.HUM - PR Newswire
Results: Humana Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
Ceredex Value Advisors LLC Increases Stake in Humana Inc. (NYSE:HUM) - MarketBeat
Humana, Cigna report Q3 earnings amid lawsuits and rumors - Healthcare Brew
Best Dental Insurance Companies Of 2024 - Forbes
New York State Teachers Retirement System Cuts Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana revenue 2008-2023 - Statista
Will Higher Expense Level Be a Woe for Humana in Q3 Earnings? - MSN
Humana Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Humana Inc. (NYSE:HUM) Q3 2024 Earnings Call Transcript - MSN
Cigna Shares Jump as CEO Dims Prospects for Humana Deal - Yahoo Finance
Cigna shares jump as CEO dims outlook on Humana deal - Modern Healthcare
Humana drops amid Cigna comments on using cash for buybacks; may dampen takeover spec - Seeking Alpha
Humana Updates 2024 EPS Guidance and Membership Growth - Yahoo Finance
Analyst recommendations: Alphabet, Meta, Humana, Microsoft, XPO... - Marketscreener.com
Humana Inc. (HUM): Among The 10 Oversold Blue Chip Stocks to Buy Now - MSN
abrdn plc Sells 14,452 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc (HUM) Q3 2024 Earnings Call Highlights: Strong EPS Guidance and Strategic Expansion ... - Yahoo Finance UK
Decoding Humana Inc (HUM): A Strategic SWOT Insight - Yahoo Finance
Humana Inc. Reports Mixed Q3 2024 Results - TipRanks
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana Q3 Earnings Beat on Growing Premiums & Cost Management - MSN
Humana updates guidance as it beats on revenue, profit in Q3 - Fierce healthcare
Is Humana Inc. (HUM) The Worst Performing S&P 500 Stock In 2024? - Insider Monkey
Humana (NYSE:HUM) Stock Price Up 4.9%Here's What Happened - MarketBeat
Humana: Q3 Earnings Snapshot - CTPost
Humana tops estimates on strength in Medicare and primary care - Reuters
Humana Delivers Upbeat Earnings Report After Setbacks - Yahoo Finance
Humana Lifts 2024 Profit Outlook As Q3 Earnings Beat Street View On Medicare Strength - Yahoo Finance UK
Humana gives upbeat earnings report after setbacks - Modern Healthcare
Humana Board Declares Payment of Quarterly Dividend to Stockholders - AOL
Humana stock on watch after Q3 beat (HUM:NYSE) - Seeking Alpha
Humana Reports Better than Expected Results for Third Quarter of 2024 - The Tokenist
Humana boosts 2024 earnings guidance thanks to Medicare Advantage member retention - Yahoo Finance
Humana Inc (HUM) Q3 2024 Earnings: EPS of $3.98 Beats Estimates, Revenue Surpasses Expectations at $29.4 Billion - GuruFocus.com
Humana Reports Better than Expected Results for Third Quarter of 2024: Guest Post by Tokenist - CoinMarketCap
Humana’s earnings boosted as Medicare Advantage membership exceeds expectations - MarketWatch
Humana Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Humana (HUM) Delivers Upbeat Earnings Report After String of Setbacks - Bloomberg
Humana Reports Third Quarter 2024 Financial Results; Updates Full Year Adjusted 2024 Financial Guidance - Business Wire
Humana Inc. (NYSE:HUM) Stock Holdings Lifted by DekaBank Deutsche Girozentrale - MarketBeat
Short Interest in Humana Inc. (NYSE:HUM) Rises By 41.6% - MarketBeat
Stormont Vail sues health insurance company Humana alleging $850K underpayment - AOL
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):